Evaluation and Management of Necrotizing Soft Tissue Infections

Infectious Disease Clinics of North America

Volumn 31, Issue 3, 2017, Pages 497-511

  Bonne, Stephanie L ^a   Kadri, Sameer S ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Gangrene; Necrotizing fasciitis; Sepsis; Soft tissue infection

Indexed keywords

BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAROLINE; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; DAPTOMYCIN; DOXYCYCLINE; IMMUNOGLOBULIN; LINEZOLID; METRONIDAZOLE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TIGECYCLINE; TIMENTIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADJUVANT THERAPY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BLOOD CULTURE; CLINICAL ASSESSMENT; COMMUNITY ACQUIRED INFECTION; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; GROUP A STREPTOCOCCAL INFECTION; HUMAN; HYPERBARIC OXYGEN THERAPY; HYPONATREMIA; LEUKOCYTOSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIPLE ORGAN FAILURE; NECROTIZING FASCIITIS; NECROTIZING SOFT TISSUE INFECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; REVIEW; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; TISSUE NECROSIS; TOXIC SHOCK SYNDROME; WOUND CARE; COMPLICATION; DISEASE MANAGEMENT; GANGRENE; INTRAVENOUS DRUG ADMINISTRATION; MICROBIOLOGY;

ADMINISTRATION, INTRAVENOUS; ANTI-BACTERIAL AGENTS; DEBRIDEMENT; DISEASE MANAGEMENT; FASCIITIS, NECROTIZING; GANGRENE; HUMANS; HYPERBARIC OXYGENATION; IMMUNOGLOBULINS; SEPSIS; SOFT TISSUE INFECTIONS;

EID: 85026863237     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2017.05.011     Document Type: Review

References (62)

1. Faraklas, I., Yang, D., Eggerstedt, M., et al. A multi-center review of care patterns and outcomes in necrotizing soft tissue infections. Surg Infect (Larchmt) 17:6 (2016), 773–778.
2. Wilson, B., Necrotizing fasciitis. Am Surg 18 (1952), 416–431.
3. Nelson, G.E., Pondo, T., Toews, K.A., et al. Epidemiology of invasive group A streptococcal infections in the United States, 2005-2012. Clin Infect Dis 63:4 (2016), 478–486.
4. Yilmazlar, T., Ozturk, E., Alsoy, A., et al. Necrotizing soft tissue infections: APACHE II score, dissemination, and survival. World J Surg 31 (2007), 1858–1862.
5. Miller, A.T., Saadai, P., Greenstein, A., et al. Postprocedural necrotizing fasciitis: A 10-year retrospective review. Am Surg 74 (2008), 405–409.
6. Lee, T.C., Carrick, M.M., Scott, B.G., et al. Incidence and clinical characteristics of methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a large urban hospital. Am J Surg 194 (2007), 809–812.
7. Hefny, A.F., Eid, H.O., Al Hussona, M., et al. Necrotizing fasciitis: a challenging diagnosis. Eur J Emerg Med 14 (2007), 50–52.
8. Childers, B.J., Potyondy, L.D., Nachreiner, R., et al. Necrotizing fasciitis: a fourteen-year retrospective study of 163 consecutive patients. Am Surg 68 (2002), 109–116.
9. Giuliano, A., Lewis, F., Hadley, K., et al. Bacteriology of necrotizing fasciitis. Am J Surg 134 (1977), 52–57.
10. Sartor, C., Limouzin-Perotti, F., Legré, R., et al. Nosocomial infections with Aeromonas hydrophila from leeches. Clin Infect Dis 35:1 (2002), E1–E5.
11. Miller, L.G., Perdreau-Remington, F., Rieg, G., et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352:14 (2005), 1445–1453.
12. Cheng, N.C., Yu, Y.C., Tai, H.C., et al. Recent trend of necrotizing fasciitis in Taiwan: focus on monomicrobial Klebsiella pneumonia necrotizing fasciitis. Clin Infect Dis 55:7 (2012), 930–939.
13. Anaya, D.A., McMahon, K., Nathens, A.B., et al. Predictors of mortality and limb loss in necrotizing soft tissue infections. Arch Surg 140:2 (2005), 151–157.
14. Bryant, A.E., Bayer, C.R., Huntinton, J.D., et al. Group A streptococcal myonecrosis: increased vimentin expression after skeletal-muscle injury mediates the binding of Streptococcus pyogenes. J Infect Dis 193:12 (2006), 1685–1692.
15. Bohach, G.A., Fast, D.J., Nelson, R.D., et al. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol 17 (1990), 251–272.
16. Darenberg, J., Luca-Harari, B., Jasir, A., et al. Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis 45:4 (2007), 450–458.
17. Stevens, D.L., Bisno, A.L., Chambers, H.F., et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 41 (2005), 1373–1406.
18. Elliott, D.C., Kufera, J.A., Myers, R.A., Necrotizing soft tissue infections: risk factors for mortality and strategies for management. Ann Surg 224 (1996), 672–683.
19. Wall, D.B., de Virgilio, C., Black, S., et al. Objective criteria may assist in distinguishing necrotizing fasciitis from nonnecrotizing soft tissue infection. Am J Surg 179 (2000), 17–21.
20. Anaya, D.A., Dellinger, E.P., Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis 44 (2007), 705–710.
21. Chan, T., Yaghoubian, A., Rosing, D., et al. Low sensitivity of physical examination findings in necrotizing soft tissue infection is improved with laboratory values: a prospective study. Am J Surg 196:6 (2008), 926–930.
22. Yaghoubian, A., de Virgilio, C., Dauphine, C., et al. Use of admission serum lactate and sodium levels to predict mortality in necrotizing soft-tissue infections. Arch Surg 142:9 (2007), 840–846.
23. Wong, C.H., Khin, L.W., Heng, K.S., et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med 32:7 (2004), 1535–1541.
24. Kincius, M., Telksnys, T., Trumbeckas, D., et al. Evaluation of LRINEC scale feasibility for predicting outcomes of Fournier gangrene. Surg Infect (Larchmt) 17:4 (2016), 448–453.
25. Chao, W.N., Tsai, S.J., Tsai, C.F., et al. The laboratory risk indicator for necrotizing fasciitis score for discernment of necrotizing fasciitis originated from Vibrio vulnificus infections. J Trauma Acute Care Surg 73:6 (2012), 1576–1582.
26. Hansen, M.B., Rasmussen, L.S., Svensson, M., et al. Association between cytokine response, the LRINEC score and outcome in patients with necrotizing soft tissue infection: a multicentre, prospective study. Sci Rep, 7, 2017, 42179.
27. Roghmann, F., von Bodman, C., Loppenberg, B., et al. Is there a need for the Fournier's gangrene severity index? Comparison of scoring systems for outcome prediction in patients with Fournier's gangrene. BJU Int 110:9 (2012), 1359–1365.
28. Carbonetti, F., Cremona, A., Carusi, V., et al. The role of contrast enhanced computed tomography in the diagnosis of necrotizing fasciitis and comparison with the laboratory risk indicator for necrotizing fasciitis (LRINEC). Radiol Med 121:2 (2016), 106–121.
29. Kim, K.T., Kim, Y.J., Won Lee, J., et al. Can necrotizing infectious fasciitis be differentiated from nonnecrotizing infectious fasciitis with MR imaging?. Radiology 259:3 (2011), 816–824.
30. Kehrl, T., Point-of-care ultrasound diagnosis of necrotizing fasciitis missed by computed tomography and magnetic resonance imaging. J Emerg Med 47:2 (2014), 172–175.
31. Green, R.J., Dafoe, D.C., Raffin, T.A., Necrotizing fasciitis. Chest 110 (1996), 219–229.
32. Hietbrink, F., Bode, L.G., Riddez, L., et al. Triple diagnostics for early detection of ambivalent necrotizing fasciitis. World J Emerg Surg, 11, 2016, 51.
33. Stevens, D.L., Bisno, A.L., Chambers, H.F., et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 59 (2014), 147–159.
34. Eckmann, C., Heizmann, W., Bodmann, K.F., et al. Tigecycline in the treatment of necrotizing soft tissue infections due to multiresistant bacteria. Surg Infect (Larchmt) 16 (2015), 618–625.
35. Zimbelman, J., Palmer, A., Todd, J., Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pedatr Infect Dis J 18:12 (1999), 1096–1100.
36. Mulla, Z.D., Leaverton, P.E., Wiersma, S.T., Invasive group A Streptococcal infections in Florida. South Med J 96:10 (2003), 968–973.
37. Bernardo, K., Pakulat, N., Fleer, S., et al. Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression. Antimicrob Agents Chemother 48 (2004), 546–555.
38. Gemmell, C.G., Ford, C.W., Virulence factor expression by gram-positive cocci exposed to subinhibitory concentrations of linezolid. J Antimicrob Chemother 50 (2002), 665–672.
39. May, A.K., Stafford, R.E., Bulger, E.M., et al., Surgical Infection Society. Treatment of complicated skin and soft tissue infections. Surg Infect (Larchmt) 10:5 (2009), 467–499.
40. Zanetti, S., Spanu, T., Deriu, A., et al. In vitro susceptibility of Vibrio spp. isolated from the environment. Int J Antimicrob Agents 17 (2001), 407–409.
41. Aravena-Román, M., Inglis, T.J., Henderson, B., et al. Antimicrobial susceptibilities of Aeromonas strains isolated from clinical and environmental sources to 26 antimicrobial agents. Antimicrob Agents Chemother 56:2 (2012), 1110–1112.
42. McHenry, C.R., Piotrowski, J.J., Petrinic, D., et al. Determinants of mortality for necrotizing soft-tissue infections. Ann Surg 221 (1995), 558–563.
43. Sudarsky, L.A., Laschinger, J.C., Coppa, G.F., et al. Improved results from a standardized approach in treating patients with necrotizing fasciitis. Ann Surg 206 (1987), 661–665.
44. Tillou, A., St Hill, C.R., Brown, C., et al. Necrotizing soft tissue infections: improved outcomes with modern care. Am Surg 70 (2004), 841–844.
45. Bilton, B.D., Zibari, G.B., McMillan, R.W., et al. Aggressive surgical management of necrotizing fasciitis serves to decrease mortality: a retrospective study. Am Surg 64 (1998), 397–400.
46. Kobayashi, L., Konstantinidis, A., Shackelford, S., et al. Necrotizing soft tissue infections: delayed surgical treatment is associated with increased number of surgical debridements and morbidity. J Trauma 71:5 (2011), 1400–1405.
47. Sartelli, M., Malangoni, M.A., May, A.K., et al. World Society of Emergency Surgery (WSES) guidelines for the management of skin and soft tissue infections. World J Emerg Surg, 9, 2014, 57.
48. Gunter, O.L., Guillamondegui, O.D., May, A.K., et al. Outcome of necrotizing skin and soft tissue infections. Surg Infect 9 (2008), 443–450.
49. Kilic, A., Aksoy, Y., Kilic, L., Fournier's gangrene: etiology, treatment, and complications. Ann Plast Surg 47 (2001), 523–527.
50. Czymek, R., Schmidt, A., Eckmann, C., et al. Fournier's gangrene: vacuum-assisted closure versus conventional dressings. Am J Surg 197 (2009), 168–176.
51. Kiyokawa, K., Takahashi, N., Rikimaru, H., et al. New continuous negative-pressure and irrigation treatment for infected wounds and intractable ulcers. Plast Reconstr Surg 120:5 (2007), 1257–1265.
52. Lee, J.Y., Jung, H., Kwon, H., et al. Extended negative pressure wound therapy-assisted dermatotraction for the closure of large open fasciotomy wounds in necrotizing faciitis patients. World J Emerg Surg 9 (2014), 29–39.
53. Linnér, A., Darenberg, J., Sjölin, J., et al. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. Clin Infect Dis 59:6 (2014), 851–857.
54. Darenberg, J., Söderquist, B., Normark, B.H., et al. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome. Clin Infect Dis 38:6 (2004), 836–842.
55. Darenberg, J., Ihendyane, N., Sjolin, J., et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 37 (2003), 333–340.
56. Shah, S.S., Hall, M., Srivastava, R., et al. Intravenous immunoglobulin in children with streptococcal toxic shock syndrome. Clin Infect Dis 49 (2009), 1369–1376.
57. Kadri, S.S., Swihart, B.J., Bonne, S.L., et al. Impact of intravenous immunoglobulin on survival in necrotizing fasciitis with vasopressor-dependent shock: a propensity-score matched analysis from 130 US hospitals. Clin Infect Dis 64:7 (2016), 877–885.
58. Madsen, M.B., Hjortrup, P.B., Hansen, M.B., et al. Immunoglobulin G for patients with necrotizing soft tissue infection (INSTINCT): a randomized, blinded, placebo-controlled trial. Intensive Care Med, 2017 [Epub ahead of print].
59. Kyles, D.M., Baltimore, J., Adjunctive use of plasmapheresis and intravenous immunoglobulin therapy in sepsis: A case report. Am J Crit Care 14 (2005), 109–112.
60. Shupak, A., Shoshani, O., Goldenberg, I., et al. Necrotizing fasciitis: An indication for hyperbaric oxygenation therapy?. Surgery 118 (1995), 873–878.
61. Jallali, N., Withey, S., Butler, P.E., Hyperbaric oxygen as adjuvant therapy in the management of necrotizing fasciitis. Am J Surg 189 (2005), 462–466.
62. Riseman, J.A., Zamboni, W.A., Curtis, A., et al. Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery 108 (1990), 847–850.